A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.
NCT00150540 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 93
Last updated 2021-06-23
Summary
The purpose of this study is to assess the safety of lanthanum carbonate in patients undergoing dialysis who have received lanthanum carbonate in the previous studies and wish to continue treatment.
Conditions
- Kidney Failure, Chronic
Interventions
- DRUG
-
Lanthanum carbonate
Sponsors & Collaborators
-
Shire
lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-10-14
- Primary Completion
- 2005-06-29
- Completion
- 2005-06-29
More Related Trials
-
Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD
NCT01128179 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Chronic Kidney Disease (CKD) Not on Dialysis
NCT01110629 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease
NCT01002872 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder
NCT04440696 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Fosrenol and Phosphorus Balance - Lanthanum Carbonate
NCT01581996 ·Status: COMPLETED ·Phase: NA
-
Long-term Study in Chronic Kidney Disease (Extension From Study 14817)
NCT01187628 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate
NCT01514851 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis
NCT06218290 ·Status: COMPLETED ·Phase: PHASE2
-
Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis
NCT03346369 ·Status: UNKNOWN ·Phase: PHASE3
-
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
NCT00567723 ·Status: COMPLETED
-
A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
NCT03545087 ·Status: WITHDRAWN ·Phase: PHASE1
-
The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
NCT02258074 ·Status: COMPLETED ·Phase: PHASE2
-
Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease
NCT00438932 ·Status: COMPLETED ·Phase: NA
-
Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients
NCT01518387 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
NCT00160121 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis
NCT05099445 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients
NCT02332811 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis
NCT00750295 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Lorlatinib Renal Impairment Study
NCT03542305 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
NCT00542815 ·Status: COMPLETED ·Phase: PHASE3
-
NI-0401 in Patients With Acute Renal Allograft Rejection
NCT00805909 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis
NCT00548249 ·Status: COMPLETED ·Phase: PHASE2
-
A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD
NCT00785629 ·Status: COMPLETED ·Phase: NA
-
Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis
NCT01736150 ·Status: COMPLETED ·Phase: PHASE3
-
Lumasiran in Hyperoxalaemic Patients on Haemodialysis
NCT06225544 ·Status: RECRUITING ·Phase: PHASE2